# Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia

> **NCT00981123** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 500 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00981123
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2011-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00981123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00981123, "Non-interventional (NI) Study to Observe Efficacy and Usage of Quetiapine in Acute Episodes of Schizophrenia and as Maintenance Therapy Following Standard Clinical Practice in Croatia". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00981123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*